Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

723 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The cancer/testis genes: review, standardization, and commentary.
Scanlan MJ, Simpson AJ, Old LJ. Scanlan MJ, et al. Among authors: old lj. Cancer Immun. 2004 Jan 23;4:1. Cancer Immun. 2004. PMID: 14738373 Review.
Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases.
Varga Z, Theurillat JP, Filonenko V, Sasse B, Odermatt B, Jungbluth AA, Chen YT, Old LJ, Knuth A, Jäger D, Moch H. Varga Z, et al. Among authors: old lj. Clin Cancer Res. 2006 May 1;12(9):2745-51. doi: 10.1158/1078-0432.CCR-05-2192. Clin Cancer Res. 2006. PMID: 16675566
CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients.
Nishikawa H, Jäger E, Ritter G, Old LJ, Gnjatic S. Nishikawa H, et al. Among authors: old lj. Blood. 2005 Aug 1;106(3):1008-11. doi: 10.1182/blood-2005-02-0607. Epub 2005 Apr 19. Blood. 2005. PMID: 15840697
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.
Matsuzaki J, Tsuji T, Luescher I, Old LJ, Shrikant P, Gnjatic S, Odunsi K. Matsuzaki J, et al. Among authors: old lj. Cancer Immunol Res. 2014 Apr;2(4):341-50. doi: 10.1158/2326-6066.CIR-13-0138. Epub 2013 Dec 17. Cancer Immunol Res. 2014. PMID: 24764581 Free PMC article.
NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells.
Gnjatic S, Altorki NK, Tang DN, Tu SM, Kundra V, Ritter G, Old LJ, Logothetis CJ, Sharma P. Gnjatic S, et al. Among authors: old lj. Clin Cancer Res. 2009 Mar 15;15(6):2130-9. doi: 10.1158/1078-0432.CCR-08-2632. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276258 Free PMC article. Clinical Trial.
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
Bender A, Karbach J, Neumann A, Jäger D, Al-Batran SE, Atmaca A, Weidmann E, Biskamp M, Gnjatic S, Pan L, Hoffman E, Old LJ, Knuth A, Jäger E. Bender A, et al. Among authors: old lj. Cancer Immun. 2007 Oct 19;7:16. Cancer Immun. 2007. PMID: 17944437 Free PMC article. Clinical Trial.
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.
Uenaka A, Wada H, Isobe M, Saika T, Tsuji K, Sato E, Sato S, Noguchi Y, Kawabata R, Yasuda T, Doki Y, Kumon H, Iwatsuki K, Shiku H, Monden M, Jungbluth AA, Ritter G, Murphy R, Hoffman E, Old LJ, Nakayama E. Uenaka A, et al. Among authors: old lj. Cancer Immun. 2007 Apr 19;7:9. Cancer Immun. 2007. PMID: 17441676 Free PMC article. Clinical Trial.
A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients.
Ayyoub M, Souleimanian NE, Godefroy E, Scotto L, Hesdorffer CS, Old LJ, Valmori D. Ayyoub M, et al. Among authors: old lj. Clin Immunol. 2006 Feb-Mar;118(2-3):188-94. doi: 10.1016/j.clim.2005.10.002. Epub 2005 Dec 20. Clin Immunol. 2006. PMID: 16368270
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
Jäger D, Karbach J, Pauligk C, Seil I, Frei C, Chen YT, Old LJ, Knuth A, Jäger E. Jäger D, et al. Among authors: old lj. Cancer Immun. 2005 Dec 12;5:11. Cancer Immun. 2005. PMID: 16335914
Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
Karbach J, Pauligk C, Bender A, Gnjatic S, Franzmann K, Wahle C, Jäger D, Knuth A, Old LJ, Jäger E. Karbach J, et al. Among authors: old lj. Int J Cancer. 2006 Feb 1;118(3):668-74. doi: 10.1002/ijc.21391. Int J Cancer. 2006. PMID: 16152624
723 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback